Clinical and Translational Medicine (CTM) is an international, peer-reviewed, and open access journal with aims at promoting and accelerating the translation of preclinical research to a clinical application and the communication between basic and clinical scientists. The journal emphasizes clinical potential and application of new biotechnologies, biomaterials, bioengineering, disease-specific biomarkers, cellular and molecular medicine, omics science, bioinformatics, applied immunology, molecular imaging, drug discovery and development,and regulation and health policy. The journal is
focused on the bench to bedside approach, favoring studies and clinical observations which generate hypotheses and questions relevant to the patient
and disease, and guide the investigations of cellular and molecular medicine. Clinical and Translational Medicine welcomes submissions from clinicians, researchers, policy makers, and the industry.

Clinical and Translational Medicine (CTM) 是同行评审的国际开放获取期刊，旨在促进临床前研究向临床应用的转化，加强基础科学家和临床科学家之间的交流。本期刊侧重于新生物技术、生物材料、生物工程、疾病特异性生物标志物、细胞和分子医学、组学科学、生物信息学、应用免疫学、分子成像、药物发现和开发以及监管和卫生政策。本期刊聚焦从实验室到临床的方法，青睐可以提出与患者和疾病相关的假设和问题的研究与临床观察，并对细胞和分子医学研究提供指导。Clinical and Translational Medicine欢迎临床医生、研究人员、政策制定者和业内人士投稿。